Form 4: InspireMD Director Paul Stuka Buys 13,431 Shares
Insider Transaction Report
InspireMD, Inc. Director Paul Stuka reported the direct acquisition of 13,431 shares of common stock at $1.62 per share.
Summary
- Paul Stuka, a Director of InspireMD, Inc. (NSPR), directly acquired 13,431 shares of common stock.
- The transaction occurred on November 12, 2025, at a price of $1.62 per share.
- Following this transaction, Paul Stuka directly beneficially owns 373,715 shares of common stock.
- Additionally, Paul Stuka indirectly beneficially owns 444,195 shares of common stock through Osiris Investment Partners, L.P.
- Paul Stuka serves as the managing member of Osiris Partners, LLC, the general partner of Osiris Investment Partners, L.P., and disclaims beneficial ownership of these indirect securities except to the extent of his pecuniary interest.
- No transaction was effected by Paul Stuka with respect to the indirectly held securities; they are included for informational purposes only.
Sentiment
Score: 7
Explanation: The direct purchase of shares by a company director is generally viewed as a positive signal, indicating management's belief in the company's value and future performance. This specific transaction, while not exceptionally large, contributes to a positive sentiment.
Positives
- A Director's direct purchase of company stock can signal confidence in the company's future prospects and valuation.
Future Outlook
NA
Industry Context
This filing is a standard insider transaction report and does not provide broader industry context or trends.
Corporate Governance
| Change Type | Description | Effective Date | Impact Assessment |
|---|---|---|---|
| Delegation of Authority | Paul Stuka granted a Power of Attorney to Michael Lawless of InspireMD, Inc. to prepare, execute, and submit SEC Forms 3, 4, and 5 on his behalf, ensuring compliance with Section 16(a) of the Exchange Act. | 11/13/2025 | This streamlines the process for Paul Stuka's SEC filings, ensuring timely and accurate reporting of his beneficial ownership and transactions in company securities. |
Related Party Transactions
- Paul Stuka indirectly beneficially owns 444,195 shares through Osiris Investment Partners, L.P., where he is the managing member of the general partner. He disclaims beneficial ownership except for his pecuniary interest, and no transaction was reported for these indirect holdings in this filing.
Stakeholder Impact
- Shareholders may view the director's purchase as a positive indicator of management confidence, potentially influencing investor sentiment.
Key Dates
| Date | Description |
|---|---|
| 11/12/2025 | Date of direct acquisition of 13,431 shares of common stock by Paul Stuka. |
| 11/13/2025 | Date of execution of the Power of Attorney by Paul Stuka and signature date of the Form 4. |
Recommendation
holdWhile a director's purchase of company stock is a positive signal, indicating confidence in the company's valuation, this single transaction of 13,431 shares is not substantial enough on its own to warrant a 'buy' recommendation. It reinforces a 'hold' position for existing investors, suggesting no immediate negative catalysts, but does not present a compelling new investment thesis without further fundamental analysis.
Keywords
InspireMD, NSPR, Paul Stuka, Director, Stock Purchase, Insider Trading, Form 4, Common Stock, Osiris Investment Partners
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.